{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T20:58:15Z","timestamp":1791925095068,"version":"4.3.4"},"reference-count":28,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,11,10]],"date-time":"2023-11-10T00:00:00Z","timestamp":1699574400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100006484","name":"Vifor Pharma","doi-asserted-by":"publisher","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}],"id":[{"id":"10.13039\/501100006484","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ard.eular.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of the Rheumatic Diseases"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1136\/ard-2023-224946","type":"journal-article","created":{"date-parts":[[2023,11,10]],"date-time":"2023-11-10T18:20:11Z","timestamp":1699640411000},"page":"394-400","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Validation of a new glucocorticoid-specific Patient-Reported Outcome Questionnaire (the Steroid PRO)"],"prefix":"10.1016","volume":"83","author":[{"given":"Susan","family":"Bridgewater","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7764-3173","authenticated-orcid":false,"given":"Mwidimi","family":"Ndosi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jill","family":"Dawson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pamela","family":"Richards","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Silverthorne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma","family":"Dures","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan M.","family":"Goodman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Hill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah L.","family":"Mackie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7939-5978","authenticated-orcid":false,"given":"Joanna C.","family":"Robson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1136\/ard-2023-224946_bib1","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1016\/j.semarthrit.2020.06.019","article-title":"The patient's perspective of the adverse effects of glucocorticoid use: a systematic review of quantitative and qualitative studies. from an OMERACT working group","volume":"50","author":"Cheah","year":"2020","journal-title":"Semin Arthritis Rheum"},{"key":"10.1136\/ard-2023-224946_bib2","first-page":"943","article-title":"A Canadian vasculitis patient-driven survey to highlight which prednisone-related side effects matter the most","volume":"41","author":"Yardimci","year":"2023","journal-title":"Clin Exp Rheumatol"},{"key":"10.1136\/ard-2023-224946_bib3","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1097\/RHU.0000000000000585","article-title":"A survey of glucocorticoid adverse effects and benefits in rheumatic diseases: the patient perspective","volume":"23","author":"Black","year":"2017","journal-title":"J Clin Rheumatol"},{"key":"10.1136\/ard-2023-224946_bib4","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.3899\/jrheum.161083","article-title":"A patient-reported outcome measure for effect of glucocorticoid therapy in adults with inflammatory diseases is needed: report from the OMERACT 2016 special interest group","volume":"44","author":"Black","year":"2017","journal-title":"J Rheumatol"},{"key":"10.1136\/ard-2023-224946_bib5","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1136\/ard.2009.114579","article-title":"Patient and rheumatologist perspectives on glucocorticoids: an exercise to improve the implementation of the European League against rheumatism (EULAR) recommendations on the management of systemic glucocorticoid therapy in rheumatic diseases","volume":"69","author":"van der Goes","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard-2023-224946_bib6","doi-asserted-by":"crossref","DOI":"10.1093\/rheumatology\/kead081","article-title":"Measuring the impact of steroid therapy on health-related quality of life in patients with rheumatic diseases: International development of a glucocorticoid treatment-specific patient-reported outcome measure","author":"Bridgewater","year":"2023","journal-title":"Rheumatology (Oxford)"},{"key":"10.1136\/ard-2023-224946_bib7","series-title":"U.S. Food and Drug Administration Center for Drug Evaluation and Research CfDaRH, Centre for Biologics Evaluation and Research","article-title":"Guidance for industry: patient-reported outcome measures: use in medical product development to support labelling claims","year":"2009"},{"key":"10.1136\/ard-2023-224946_bib8","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1007\/s11136-011-9903-x","article-title":"Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L)","volume":"20","author":"Herdman","year":"2011","journal-title":"Qual Life Res"},{"key":"10.1136\/ard-2023-224946_bib9","doi-asserted-by":"crossref","first-page":"251","DOI":"10.4066\/AMJ.2012.952","article-title":"Scale construction Utilising the Rasch Unidimensional measurement model: a measurement of adolescent attitudes towards abortion","volume":"5","author":"Hendriks","year":"2012","journal-title":"Australas Med J"},{"key":"10.1136\/ard-2023-224946_bib10","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1002\/art.23108","article-title":"The Rasch measurement model in rheumatology: what is it and why use it? when should it be applied, and what should one look for in a Rasch paper","volume":"57","author":"Tennant","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard-2023-224946_bib11","first-page":"205","article-title":"Detecting and evaluating the impact of multidimensionality using item fit statistics and principal component analysis of residuals","volume":"3","author":"Smith","year":"2002","journal-title":"J Appl Meas"},{"key":"10.1136\/ard-2023-224946_bib12","first-page":"857","article-title":"Observations are always ordinal; measurements, however, must be interval","volume":"70","author":"Wright","year":"1989","journal-title":"Arch Phys Med Rehabil"},{"key":"10.1136\/ard-2023-224946_bib13","series-title":"Measurement in Medicine: A Practical Guide","article-title":"Measurement in medicine","author":"de Vet","year":"2011"},{"key":"10.1136\/ard-2023-224946_bib14","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1007\/s11136-014-0632-9","article-title":"Getting serious about test-retest reliability: a critique of retest research and some recommendations","volume":"23","author":"Polit","year":"2014","journal-title":"Qual Life Res"},{"key":"10.1136\/ard-2023-224946_bib15","first-page":"1082","article-title":"DIF matters: a practical approach to test if differential item functioning makes a difference","volume":"20","author":"Tennant","year":"2007","journal-title":"Rasch Measurement Transactions"},{"key":"10.1136\/ard-2023-224946_bib16","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1136\/annrheumdis-2016-210002","article-title":"Development of a glucocorticoid toxicity index (GTI) using multicriteria decision analysis","volume":"76","author":"Miloslavsky","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard-2023-224946_bib17","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/s12955-017-0609-9","article-title":"Development of the systemic lupus erythematosus steroid questionnaire (SSQ): a novel patient-reported outcome tool to assess the impact of oral steroid treatment","volume":"15","author":"Mathias","year":"2017","journal-title":"Health Qual Life Outcomes"},{"key":"10.1136\/ard-2023-224946_bib18","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1111\/j.1751-5823.2010.00112.x","article-title":"Selection bias in web surveys","volume":"78","author":"Bethlehem","year":"2010","journal-title":"Int Statistical Rev"},{"key":"10.1136\/ard-2023-224946_bib19","doi-asserted-by":"crossref","first-page":"3409","DOI":"10.1093\/rheumatology\/kead094","article-title":"The impact of health literacy: associations with disease activity and medication prescription in patients with rheumatoid arthritis","volume":"62","author":"Gorter","year":"2023","journal-title":"Rheumatology (Oxford)"},{"key":"10.1136\/ard-2023-224946_bib20","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1002\/acr.24480","article-title":"Addressing health literacy needs in rheumatology: which patient health literacy profiles need the attention of health professionals","volume":"73","author":"Bakker","year":"2021","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"Suppl 2","key":"10.1136\/ard-2023-224946_bib21","doi-asserted-by":"crossref","first-page":"ii35","DOI":"10.1093\/rap\/rkab053","article-title":"Factors associated with patient activation in inflammatory arthritis: a multisite cross-sectional study","volume":"5","author":"Jones","year":"2021","journal-title":"Rheumatol Adv Pract"},{"key":"10.1136\/ard-2023-224946_bib22","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1038\/s41584-021-00690-3","article-title":"Publisher correction: global epidemiology of systemic lupus erythematosus","volume":"17","author":"Barber","year":"2021","journal-title":"Nat Rev Rheumatol"},{"key":"10.1136\/ard-2023-224946_bib23","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/s41687-018-0061-6","article-title":"How do patient reported outcome measures (Proms) support clinician-patient communication and patient care? A realist synthesis","volume":"2","author":"Greenhalgh","year":"2018","journal-title":"J Patient Rep Outcomes"},{"key":"10.1136\/ard-2023-224946_bib24","doi-asserted-by":"crossref","first-page":"233","DOI":"10.2147\/PROM.S156291","article-title":"Proms data: can it be used to make decisions for individual patients? A narrative review","volume":"10","author":"Field","year":"2019","journal-title":"Patient Relat Outcome Meas"},{"key":"10.1136\/ard-2023-224946_bib25","doi-asserted-by":"crossref","DOI":"10.2196\/10815","article-title":"Patient perspectives on the challenges and responsibilities of living with chronic inflammatory diseases: qualitative study","volume":"10","author":"Macdonald","year":"2018","journal-title":"J Particip Med"},{"key":"10.1136\/ard-2023-224946_bib26","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.jval.2016.01.007","article-title":"Assessing asthma symptoms in adolescents and adults: qualitative research supporting development of the asthma daily symptom diary","volume":"19","author":"Gater","year":"2016","journal-title":"Value Health"},{"key":"10.1136\/ard-2023-224946_bib27","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.ijnurstu.2018.07.017","article-title":"Living with inflammatory bowel disease: a review of qualitative research studies","volume":"87","author":"Fourie","year":"2018","journal-title":"Int J Nurs Stud"},{"key":"10.1136\/ard-2023-224946_bib28","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1111\/jocn.15080","article-title":"Challenges of living with and managing inflammatory bowel disease: a meta-synthesis of patients' experiences","volume":"29","author":"Byron","year":"2020","journal-title":"J Clin Nurs"}],"container-title":["Annals of the Rheumatic Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496724003674?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496724003674?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/ard-2023-224946","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,14]],"date-time":"2025-02-14T08:19:22Z","timestamp":1739521162000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003496724003674"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":28,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,3]]}},"alternative-id":["S0003496724003674"],"URL":"https:\/\/doi.org\/10.1136\/ard-2023-224946","relation":{},"ISSN":["0003-4967"],"issn-type":[{"value":"0003-4967","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Validation of a new glucocorticoid-specific Patient-Reported Outcome Questionnaire (the Steroid PRO)","name":"articletitle","label":"Article Title"},{"value":"Annals of the Rheumatic Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1136\/ard-2023-224946","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2024 \u00a9 Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY. Published by Elsevier Inc. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}